Abstract:Insulin resistance caused by the overexpression of protein tyrosine phosphatase 1 B (PTP1B) as well as the dephosphorylation of its target is one of the main causes of type 2 diabetes (T2D). A newly discovered proteoglycan, Fudan-Yueyang Ganoderma lucidum (FYGL) extracted from Ganoderma lucidum, was first reported to be capable of competitively inhibiting PTP1B activity in vitro in our previous work. In the present study, we sought to reveal the mechanism of PTP1B inhibition by FYGL at the animal and cellular levels. We found that FYGL can decrease blood glucose, reduce body weight and ameliorate insulin resistance in ob/ob mice. Decrease of PTP1B expression and increase of the phosphorylation of PTP1B targets in the insulin signaling pathway of skeletal muscles were observed. In order to clearly reveal the underlying mechanism of the hypoglycemic effect caused by FYGL, we further investigated the effects of FYGL on the PTP1B-involved insulin signaling pathway in rat myoblast L6 cells. We demonstrated that FYGL had excellent cell permeability by using a confocal laser scanning microscope and a flow cytometer. We found that FYGL had a positive effect on insulin-stimulated glucose uptake by using the 2-deoxyglucose (2-DG) method. FYGL could inhibit PTP1B expression at the mRNA level, phosphorylating insulin receptor substrate-1 (IRS1), as well as activating phosphatidylinositol-3 kinase (PI3K) and protein kinase B (Akt). Finally, FYGL increased the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and consequently up-regulated the expression of glucose transporter type 4 (GLUT4), promoting GLUT4 transportation to the plasma membrane in PTP1B-transfected L6 cells. Our study provides theoretical evidence for FYGL to be potentially used in T2D management.

Structural Characterization and Bioactivity Evaluation of an Acidic Proteoglycan Extract from Ganoderma Lucidum Fruiting Bodies for PTP1B Inhibition and Anti-Diabetes.

Isolation and Characterization of a Hyperbranched Proteoglycan from Ganoderma Lucidum for Anti-Diabetes

Interaction and Inhibition of a Ganoderma Lucidum Proteoglycan on PTP1B Activity for Anti-diabetes.

A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice.

Antidiabetic, Antihyperlipidemic and Antioxidant Activities of a Novel Proteoglycan from Ganoderma Lucidum Fruiting Bodies on Db/db Mice and the Possible Mechanism.

Hypoglycemic Mechanism of a Novel Proteoglycan, Extracted from Ganoderma Lucidum, in Hepatocytes

A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway

Inhibition on α-Glucosidase Activity and Non-Enzymatic Glycation by an Anti-Oxidative Proteoglycan from Ganoderma lucidum

Effect of a Novel Proteoglycan PTP1B Inhibitor from Ganoderma Lucidum on the Amelioration of Hyperglycaemia and Dyslipidaemia in Db/db Mice.

Endocytosis Mechanism Of A Novel Proteoglycan, Extracted From Ganoderma Lucidum, In Hepg2 Cells

The thermodynamic and kinetic mechanisms of a<i> Ganoderma</i><i> lucidum</i> proteoglycan inhibiting hIAPP amyloidosis

Effects of a Ganoderma lucidum Proteoglycan on Type 2 Diabetic Rats and the Recovery of Rat Pancreatic Islets

Structure Characterization of a Novel Neutral Polysaccharide Isolated from Ganoderma Lucidum Fruiting Bodies.

Extraction, Structural Characterization, and Immunomodulatory Activity of a High Molecular Weight Polysaccharide From Ganoderma lucidum

Biodistribution and Immunomodulatory Activities of a Proteoglycan Isolated from Ganoderma Lucidum

Structure of a Polysaccharide from Gastrodia Elata Bl., and Oligosaccharides Prepared Thereof with Anti-Pancreatic Cancer Cell Growth Activities

Effects of a<i> Ganoderma</i><i> lucidum</i> Proteoglycan on Type 2 Diabetic Rats and the Recovery of Rat Pancreatic Islets

Hypoglycemic Effect and Mechanism of a Pectic Polysaccharide with Hexenuronic Acid from the Fruits of Ficus Pumila L. in C57BL/KsJ Db/db Mice.

Modulation of energy metabolism and mitochondrial biogenesis by a novel proteoglycan from Ganoderma lucidum

Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum

Structural Characterization and Immunomodulatory Activity of a Water-Soluble Polysaccharide from Ganoderma Leucocontextum Fruiting Bodies.